Singapore, May 15 -- A fully integrated biopharmaceutical company Uni-Bio Science Group Limited announced on 15 May 2020 that its wholly-owned subsidiary Shenzhen Watsin Genetech Limited (Watsin) reached a partnership with Chengdu Medlinker Technology Company Limited (Medlink), to further develop digital marketing channels for the Group's products, and to expand industry value chain downstream to pharmaceutical E-commerce. According to the agreement, both companies will start working on Genetime(R), expanding its marketing channel to dermatology related clinical experts, and will collaborate across several verticals, including smart healthcare, disease management, patient and clinical practitioner education, academic marketing, healthcare...